TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · no major macro event
ENTX

Entera Bio Ltd

Healthcare · Biotechnology

3.10$ -3.4% vs. previous close Closing price · As of: Nov 13, 2026

Filings

Filings

Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Entera Bio Ltd (ENTX) with date, type and a link to the original document.

Filings ENTX
Date Type Filing Original
11/06/2026 Current report (8-K) Entera Bio Ltd. (ENTX): Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Exhibits View report ↗
10/27/2026 Current report (8-K) Entera Bio Ltd. (ENTX): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure; Financial Statements and Exhibits View report ↗
10/06/2026 Current report (8-K) Entera Bio Ltd. (ENTX): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure; Financial Statements and Exhibits View report ↗
08/18/2026 Current report (8-K) Entera Bio Ltd. (ENTX): Regulation FD Disclosure; Other Events; Financial Statements and Exhibits View report ↗

Showing the 100 most recent filings of the selected type.

Data as of: November 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?